Integrichain Blog

Blog

Pharmaceutical team discussing the future of the pharmaceutical industry

Specialty Pharmacy William Roth
July 12, 2023

Thoughts Following Asembia 2023 Part 3: Specialty Lite and Emerging Distribution...

4 Minute Read

Channel expert Bill Roth shares information on specialty lite and emerging distribution models.

Stethoscope and pharmaceutical drugs

Contracts & Pricing Ben Fanelli Jeff Baab Nick Iaconi Carter Hall
June 28, 2023

IRA Updates, The Rise of Medical Benefit Contracting, and New CMS...

8 Minute Read

Updates on IRA Updates, The Rise of Medical Benefit Contracting, and the New CMS Proposed Rule.

Pharmaceutical team discussing the future of the pharmaceutical industry

Specialty Pharmacy William Roth
June 23, 2023

Thoughts Following Asembia 2023 Part 2: Fragmentation and Disruption in the...

3 Minute Read

Channel expert Bill Roth explores how we are seeing an unprecedented level of changes and transformation in the industry.

Gross-to-Net Melinda Malave
June 8, 2023

Monitoring the Gross-to-Net Impacts of WAC Price Increases

2 Minute Read

Manufacturers considering taking a WAC price increase this year should be aware of the impact on their GTN line items.

Pharmaceutical industry market access updates

Contracts & Pricing Rupal Patel Jyoti Dubey Olivia Nweze
May 31, 2023

Puerto Rico Medicaid Drug Rebate Program Claims Administrator, TAA Compliance and...

3 Minute Read

Updates on US Territory Enrollment Updates, Puerto Rico Medicaid Drug Rebate Program Claims Administrator, TAA Compliance and its Relevance to FSS Agreements, and State Price Transparency Reporting Updates.

Pharmaceutical team discussing the future of the pharmaceutical industry

Specialty Pharmacy William Roth
May 15, 2023

Thoughts Following Asembia 2023 Part 1: Exploring the New Pharmacy Landscape

2 Minute Read

Channel expert Bill Roth explores how specialty pharmacy has evolved and their take on the current landscape and insights for pharmaceutical organizations.

340b contract pharmacy

Contracts & Pricing Rupal Patel Michael Gorokhovsky Carter Hall
April 24, 2023

340B Contract Pharmacy Restrictions, M&A Funding in Biotech & FDA Accelerated...

6 Minute Read

Updates on 340B Contract Pharmacy Restriction Updates, M&A and Venture Capital Funding in Biotech, and Stricter Accelerated Approval Criteria Proposed for FDA.

pharma digital transformation

Gross-to-Net Manli Gomari
April 17, 2023

Why Modernize Your Gross-to-Net? 5 Benefits of Pharma Digital Transformation

2 Minute Read

In the current pharma landscape, more than 80% of manufacturers still rely on manual processes to accrue, forecast, and report their gross-to-net (GTN) deductions. This is primarily because of...

Government Pricing John Whitridge
April 7, 2023

State Pricing Transparency Reporting – Part 2

3 Minute Read

Explore the best practice recommendations regarding compliance for SPTR.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article